| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.015 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |